Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX.DL)

CAPS Rating: No stars

A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.


Player Avatar naughtyguy (33.49) Submitted: 6/21/2012 12:23:47 PM : Underperform Start Price: $63.44 ONXX.DL Score: -21.02

$ 4billion market cap?

Member Avatar kcain71 (36.95) Submitted: 6/21/2012 6:15:53 PM
Recs: 0

I agree. I hope we're right because I just shorted 100 shrs (real $)!

Featured Broker Partners